Did Xenoport and These Stocks Miss or Beat Analyst Expectations?

Xenoport, Inc. (NASDAQ:XNPT) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.51 in the quarter versus EPS of $-0.22 in the year-earlier quarter. Revenue Decreased 79.77% to $2.1 million from the year-earlier quarter.

Xenoport, Inc. reported adjusted EPS loss of $0.51 per share. By that measure, the company beat the mean analyst estimate of $-0.53. It beat the average revenue estimate of $1.74 million.

XNPT 20130811

Avanir Pharmaceuticals (NASDAQ:AVNR) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.08 in the quarter versus EPS of $-0.11 in the year-earlier quarter. Revenue Rose 87.86% to $19.8 million from the year-earlier quarter.

Avanir Pharmaceuticals reported adjusted EPS loss of $0.08 per share. By that measure, the company beat the mean analyst estimate of $-0.11. It beat the average revenue estimate of $19.53 million.

AVNR 20130811

Exelixis, Inc. (NASDAQ:EXEL) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.34 in the quarter versus EPS of $-0.25 in the year-earlier quarter. Revenue Rose 52.37% to $11.9 million from the year-earlier quarter.

Exelixis, Inc. reported adjusted EPS loss of $0.34 per share. By that measure, the company missed the mean analyst estimate of $-0.30. It beat the average revenue estimate of $6.55 million.

EXEL 20130811

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.03 in the quarter versus EPS of $0.09 in the year-earlier quarter. Revenue Decreased 42.6% to $7.1 million from the year-earlier quarter.

Cumberland Pharmaceuticals, Inc. reported adjusted EPS loss of $0.03 per share. By that measure, the company missed the mean analyst estimate of $0.02. It missed the average revenue estimate of $9.4 million.

CPIX 20130811

Cross Country Healthcare, Inc. (NASDAQ:CCRN) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.05 in the quarter versus EPS of $-0.08 in the year-earlier quarter. Revenue Decreased 12.28% to $110.77 million from the year-earlier quarter.

Cross Country Healthcare, Inc. reported adjusted EPS loss of $0.05 per share. By that measure, the company missed the mean analyst estimate of $-0.01. It beat the average revenue estimate of $110.75 million.

CCRN 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.